Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-25 @ 3:45 AM
NCT ID:
NCT03510702
Eligibility Criteria:
Inclusion Criteria:
Group of periodontal patients:
1. Clinical criteria: at least 3 locations in unirradicular teeth with PD 6 mm. 3 samples will be taken from each of these 3 locations (9 total samples). Third molars are not included in the study.
2. Patients not treated periodontally.
3. 30-60 years.
Periodontally healthy group:
1\. Absence of clinical and radiographical periodontal pathology.
Exclusion Criteria:
* Group of periodontal patients:
1. Aggressive Periodontal Disease (Armitage, 1999).
2. Patients with controlled periodontal disease with plaque and gingival indexes ≤20%.
3. Patients with systemic diseases or taking medications that alter bone metabolism (Osteoporosis, arthritis, hormonal treatment, bisphosphonates, anti-inflammatory, immunosuppressants, etc ...).
4. Patients with antibiotic, anti-inflammatory or contraceptive treatment in the previous 3 months or taking antiaggregants in the last 7 days before taking the sample.
5. Smokers (\> 10 cig. /day).
6. Pregnant or breast-feeding.
Periodontally healthy group:
1. Patients with systemic diseases or taking medications that alter bone metabolism (Osteoporosis, arthritis, hormonal treatment, bisphosphonates, anti-inflammatory, immunosuppressant...).
2. Patients with antibiotic, anti-inflammatory or contraceptive treatment in the previous 3 months or taking antiaggregants in the last 7 days before taking the sample.
3. Smokers (\> 10 cig/day).
4. Pregnant or breast-feeding.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
60 Years
Study:
NCT03510702
Study Brief:
Protocol Section:
NCT03510702